These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 9231684)

  • 41. Results of a prospective trial of mantle irradiation alone for selected patients with early-stage Hodgkin's disease.
    Backstrand KH; Ng AK; Takvorian RW; Jones EL; Fisher DC; Molnar-Griffin BJ; Silver B; Tarbell NJ; Mauch PM
    J Clin Oncol; 2001 Feb; 19(3):736-41. PubMed ID: 11157025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial.
    Mauch PM; Canellos GP; Shulman LN; Silver B; Tarbell NJ; Come S; Rabin MS; Coleman CN
    J Clin Oncol; 1995 Apr; 13(4):947-52. PubMed ID: 7707123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The EORTC treatment of early stages of Hodgkin's disease: the role of radiotherapy.
    Tubiana M; Henry-Amar M; Hayat M; Burgers M; Qasim M; Somers R; Sizoo W; van der Schueren E
    Int J Radiat Oncol Biol Phys; 1984 Feb; 10(2):197-210. PubMed ID: 6368491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid.
    Rubio R
    Cancer; 1994 May; 73(9):2400-7. PubMed ID: 8168044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
    Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term results of a prospective trial of mantle irradiation alone for early-stage Hodgkin's disease.
    Ng AK; Li S; Neuberg D; Fisher DC; McMillan C; Silver B; Marcus KC; Stevenson MA; Mauch PM
    Ann Oncol; 2006 Nov; 17(11):1693-7. PubMed ID: 17018702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stage I-III Hodgkin's disease: outcome and pattern of failure following treatment with radiation therapy and chemotherapy in a modern era.
    Zapatero A; López MA; Cerezo L; De Vidales CM; MarIn A; Pérez-Torrubia A
    Hematology; 2002 Feb; 7(1):43-50. PubMed ID: 12171776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
    Hodgson DC; Tsang RW; Pintilie M; Sun A; Wells W; Crump M; Gospodarowicz MK
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1374-81. PubMed ID: 14630276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
    Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
    J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of nonlaparotomized (clinical) stage I and II Hodgkin's disease patients by extended field and splenic irradiation.
    Coleman M; Kaufmann T; Nisce LZ; Leonard JP
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1235-8. PubMed ID: 10725636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous supra- and infradiaphragmatic irradiation in Hodgkin's disease.
    Krueck W; Hess CF; Kortmann RD; Bamberg M
    Br J Radiol; 1993 Aug; 66(788):703-10. PubMed ID: 7719683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
    Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
    J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiation therapy for early stage Hodgkin's disease: Australasian patterns of care. Australasian Radiation Oncology Lymphoma Group.
    Barton M; Boyages J; Crennan E; Davis S; Fisher RJ; Hook C; Johnson N; Joseph D; Liew KH; Morgan G
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):227-36. PubMed ID: 7836074
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of early clinically staged Hodgkin's disease with a combination of ABVD chemotherapy plus limited field radiotherapy.
    Karmiris TD; Grigoriou E; Tsantekidou M; Spanou E; Mihalakeas H; Baltadakis J; Apostolidis J; Pagoni M; Karakasis D; Bakiri M; Mitsouli C; Harhalakis N; Nikiforakis E
    Leuk Lymphoma; 2003 Sep; 44(9):1523-8. PubMed ID: 14565654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.
    Anderson H; Deakin DP; Wagstaff J; Jones JM; Todd ID; Wilkinson PM; James RD; Steward WP; Blackledge G; Scarffe JH
    Br J Cancer; 1984 Jun; 49(6):695-702. PubMed ID: 6375711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mantle irradiation alone for clinical stage I-II Hodgkin's disease: long-term follow-up and analysis of prognostic factors in 261 patients.
    Wirth A; Chao M; Corry J; Laidlaw C; Yuen K; Ryan G; Byram D; Davis S; Kiffer J; Quong G; Liew K
    J Clin Oncol; 1999 Jan; 17(1):230-40. PubMed ID: 10458238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.